- Home
- ACEL vs EYPT Comparison
ACEL vs EYPT Comparison
Compare ACEL & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | EYPT |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.7M | 1.3B |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ACEL | EYPT |
|---|---|---|
| Price | $12.37 | $13.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $14.67 | ★ $31.80 |
| AVG Volume (30 Days) | 268.7K | ★ 786.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.34 | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | N/A | ★ $7,539,000.00 |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $2.81 | $3,115.57 |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.55 | $5.46 |
| 52 Week High | $13.31 | $19.11 |
Technical Indicators
Market Signals| Indicator | ACEL | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 64.39 | 43.22 |
| Support Level | $10.79 | $12.47 |
| Resistance Level | $12.92 | $13.32 |
| Average True Range (ATR) | 0.24 | 0.63 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 79.68 | 27.50 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.